• 1
    Preux PM, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005;4: 2131.
  • 2
    Meinardi H, Scott RA, Reis R, et al.. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001;42: 13649.
  • 3
    Scott RA, Lhatoo SD, Sander JWAS. The treatment of epilepsy in developing countries: where do we go from here? Bull WHO 2001;79: 34451.
  • 4
    Petralanda I. Quality of antimalarial drugs and resistance to Plasmodium vivax in the Amazonian region. Lancet 1995;345: 1433.
  • 5
    Ten Mam M. Counterfeit drugs: implications for health. Adverse Drug React Toxicol Rev 1992;11: 5965.
  • 6
    Wondemagegnehu E. Counterfeit and substandard drugs in Myanmar and Vietnam. Geneva : WHO , 1999.
  • 7
    Shakoor O, Taylor RB, Behrens RH. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health 1997;2: 83945.
  • 8
    Taylor RB, Shakoor O, Behrens RH, et al.. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 2001;357: 19336.
  • 9
    REMED/OMS. La qualité des médicaments sur le marché pharmaceutique africain: étude analytique dans 3 pays: Cameroun, Madagascar, Tchad. WHO/DAP 1995.
  • 10
    Raggi MA, Casamenti G, Mandrioli R, et al.. A rapid LC method for the identification and determination of CNS drugs in pharmaceutical formulations. J Pharm Biomed Anal 2000;23: 1617.
  • 11
    European pharmacopeia. 4th ed. Strasbourg : Editions de l'Europe, 2002.
  • 12
    WHO. Le secteur pharmaceutique privé commercial au Maroc. WHO/DAP 1997. Available at
  • 13
    Fauci AS, Braunwald E, Isselbacher KJ, et al.. Harrison's principles of internal medicine. 14th ed. New York : McGraw-Hill, 1998.
  • 14
    Oluka MO, Mitema ES, Kibwage IO, et al.. A comparative bioavailability of four carbamazepine tablet formulations available in the Kenya market. East Afr Med J 1996;73: 3236.
  • 15
    Farnarier G, Nimaga K, Desplats D, et al.. Traitement des épileptiques en milieu rural au Mali. Rev Neurol 2002;158: 8158.